CAMBRIDGE, Mass.--(BUSINESS WIRE)--Today, Portal Biotechnologies, Inc. (“Portal”), a cell engineering platform company, announced a $5M pre-seed round led by Pear VC, with participation from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback